HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of itraconazole in preventing and treating systemic fungal infections in immunocompromised patients.

Abstract
The increasing use of immunosuppressive chemotherapy and allogeneic transplants for haematological malignancies has increased the number of patients at risk of systemic fungal infections (SFIs). A number of antifungal agents are now available. This paper reports the deliberations of an expert panel that considered the role of itraconazole. It concluded that itraconazole has an important role in the prophylaxis and treatment of SFIs whether proven or not.
AuthorsM Potter, J P Donnelly
JournalActa haematologica (Acta Haematol) Vol. 111 Issue 3 Pg. 175-80 ( 2004) ISSN: 0001-5792 [Print] Switzerland
PMID15034243 (Publication Type: Congress)
CopyrightCopyright 2004 S. Karger AG, Basel
Chemical References
  • Itraconazole
Topics
  • Drug Interactions
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Immunocompromised Host
  • Itraconazole (administration & dosage, therapeutic use)
  • Mycoses (drug therapy, etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: